| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy
|
Khouri, I.F.
|
|
|
10 |
11 |
p. 1293-1297
|
artikel
|
| 2 |
Allogeneic hematopoietic transplantation for mantle-cell lymphoma:Molecular remissions and evidence of graft-versus-malignancy
|
I. F. Khouri
|
|
1999
|
10 |
11 |
p. 1293-1299
7 p.
|
artikel
|
| 3 |
A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
|
Cascinu, S.
|
|
|
10 |
11 |
p. 1377-1379
|
artikel
|
| 4 |
A phase III study of gemcitabine and docetaxel in advancedpancreatic cancer: A report from the Italian Group for the Study of DigestiveTract Cancer (GISCAD)
|
S. Cascinu
|
|
1999
|
10 |
11 |
p. 1377-1379
3 p.
|
artikel
|
| 5 |
Awards, appointments
|
|
|
|
10 |
11 |
p. 1264
|
artikel
|
| 6 |
Book review
|
Cavalli, F.
|
|
|
10 |
11 |
p. 1267
|
artikel
|
| 7 |
Book review
|
Zappa, F.
|
|
|
10 |
11 |
p. 1396
|
artikel
|
| 8 |
Book review
|
Leoncini-Franscini, L.
|
|
|
10 |
11 |
p. 1270
|
artikel
|
| 9 |
Book review
|
Bertoni, F.
|
|
|
10 |
11 |
p. 1268
|
artikel
|
| 10 |
Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: Induction of remission by the monoclonal antibody Trastuzumab
|
Kollmannsberger, C.
|
|
|
10 |
11 |
p. 1393-1394
|
artikel
|
| 11 |
Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: Induction ofremission by the monoclonal antibody Trastuzumab
|
C. Kollmannsberger
|
|
1999
|
10 |
11 |
p. 1393-1394
2 p.
|
artikel
|
| 12 |
Contents of the next issue
|
|
|
|
10 |
11 |
p. vi
|
artikel
|
| 13 |
Copyright
|
|
|
|
10 |
11 |
p. iv
|
artikel
|
| 14 |
Cytomegalovirus colitis after administration of docetaxel-5-fluorouracil-cisplatin chemotherapy for locally advanced hypopharyngeal cancer
|
Van den Brande, J.
|
|
|
10 |
11 |
p. 1369-1372
|
artikel
|
| 15 |
Cytomegalovirus colitis after administration ofdocetaxel5-fluorouracilcisplatin chemotherapy for locallyadvanced hypopharyngeal cancer
|
J. Van den Brande
|
|
1999
|
10 |
11 |
p. 1369-1372
4 p.
|
artikel
|
| 16 |
Decision failed over revisions to declaration of Helsinki
|
|
|
|
10 |
11 |
p. 1263-1264
|
artikel
|
| 17 |
D. H. Johnson, J. Klastersky (eds)., Taxanes in lung cancertherapy.
|
F. Zappa
|
|
1999
|
10 |
11 |
p. 1396-1396
1 p.
|
artikel
|
| 18 |
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group
|
Dimopoulos, M.A.
|
|
|
10 |
11 |
p. 1385-1388
|
artikel
|
| 19 |
Docetaxel and cisplatin combination chemotherapy in advanced carcinomaof the urothelium: A multicenter phase II study of the Hellenic CooperativeOncology Group
|
M. A. Dimopoulos
|
|
1999
|
10 |
11 |
p. 1385-1388
4 p.
|
artikel
|
| 20 |
Editorial Board
|
|
|
|
10 |
11 |
p. v
|
artikel
|
| 21 |
Epirubicin, cisplatin and oral UFTwith leucovorin (‘ECU’): A phase I–II study in patients with advanced upper gastrointestinal tract cancer
|
Seymour, M.T.
|
|
|
10 |
11 |
p. 1329-1333
|
artikel
|
| 22 |
Epirubicin, cisplatin and oral UFT with leucovorin (ECU): A phaseIII study in patients with advanced upper gastrointestinal tractcancer
|
M. T. Seymour
|
|
1999
|
10 |
11 |
p. 1329-1333
5 p.
|
artikel
|
| 23 |
Ethics and HIV treatments: Al Gore under fire
|
Antonini, Robertto
|
|
|
10 |
11 |
p. 1261-1262
|
artikel
|
| 24 |
Ethics and HIV treatments: Al Gore under fire; HIV-control, main healthgoal for South Africa; Next stop PubMed Central; Judge allowsoff-label drugs material; Decision failed over revisions to declaration ofHelsinki; Awards, appointments; Perhaps not everyone knows that...
|
|
|
1999
|
10 |
11 |
p. 1261-1267
7 p.
|
artikel
|
| 25 |
Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA
|
Sausville, E.A.
|
|
|
10 |
11 |
p. 1287-1292
|
artikel
|
| 26 |
Evolving approaches to cancer drug discovery and development at theNational Cancer Institute, USA
|
E. A. Sausville
|
|
1999
|
10 |
11 |
p. 1287-1291
5 p.
|
artikel
|
| 27 |
Friedreich's ataxia and intrathecal chemotherapy in a patient with lymphoblastic lymphoma
|
De Pas, T.
|
|
|
10 |
11 |
p. 1393
|
artikel
|
| 28 |
Friedreichs ataxia and intrathecal chemotherapy in a patient withlymphoblastic lymphoma
|
T. De Pas
|
|
1999
|
10 |
11 |
p. 1393-1393
1 p.
|
artikel
|
| 29 |
G. R. Lee, J. Foerster et al. (eds)., Wintrobes clinicalhematology
|
L. Leoncini-Franscini
|
|
1999
|
10 |
11 |
p. 1270-1270
1 p.
|
artikel
|
| 30 |
Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)
|
Locatelli, M.
|
|
|
10 |
11 |
p. 1394-1395
|
artikel
|
| 31 |
Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (cmfregimen)
|
M. Locatelli
|
|
1999
|
10 |
11 |
p. 1394-1395
2 p.
|
artikel
|
| 32 |
HIV-control, main health goal for South Africa
|
|
|
|
10 |
11 |
p. 1262
|
artikel
|
| 33 |
Importance-satisfaction discrepancies are associated with health-related quality of life in five-year survivors of endocrine gastrointestinal tumours
|
Larsson, G.
|
|
|
10 |
11 |
p. 1321-1327
|
artikel
|
| 34 |
Importance-satisfaction discrepancies are associated with health-relatedquality of life in five-year survivors of endocrine gastrointestinaltumours
|
G. Larsson
|
|
1999
|
10 |
11 |
p. 1321-1327
7 p.
|
artikel
|
| 35 |
Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: A phase II trial
|
Fields-Jones, S.
|
|
|
10 |
11 |
p. 1307-1310
|
artikel
|
| 36 |
Improvements in clinical benefit with vinorelbine in the treatment ofhormone-refractory prostate cancer: A phase II trial
|
S. Fields-Jones
|
|
1999
|
10 |
11 |
p. 1307-1310
4 p.
|
artikel
|
| 37 |
In this issue
|
|
|
|
10 |
11 |
p. vi
|
artikel
|
| 38 |
Judge allows off-label drugs material
|
|
|
|
10 |
11 |
p. 1263
|
artikel
|
| 39 |
Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam)
|
Lofts, F.J.
|
|
|
10 |
11 |
p. 1389-1392
|
artikel
|
| 40 |
Management of adenocarcinoma of unknown primary with a5-fluorouracilcisplatin chemotherapy regimen (CFTam)
|
F. J. Lofts
|
|
1999
|
10 |
11 |
p. 1389-1392
4 p.
|
artikel
|
| 41 |
M. Fiorentino (ed)., Diagnostic approach to clinical oncology
|
F. Cavalli
|
|
1999
|
10 |
11 |
p. 1267-1267
1 p.
|
artikel
|
| 42 |
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder
|
Benson, M.C.
|
|
|
10 |
11 |
p. 1269-1270
|
artikel
|
| 43 |
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder
|
Sternberg, C.N.
|
|
|
10 |
11 |
p. 1301-1305
|
artikel
|
| 44 |
Neo-adjuvant chemotherapy and bladder preservation in locally advancedtransitional cell carcinoma of the bladder
|
C. N. Sternberg
|
|
1999
|
10 |
11 |
p. 1301-1305
5 p.
|
artikel
|
| 45 |
Neo-adjuvant chemotherapy and bladder preservation in locally advancedtransitional cell carcinoma of the bladder
|
M. C. Benson
|
|
1999
|
10 |
11 |
p. 1269-1270
2 p.
|
artikel
|
| 46 |
Neoplastic complications of HIV infection
|
Spina, M.
|
|
|
10 |
11 |
p. 1271-1286
|
artikel
|
| 47 |
Neoplastic complications of HIV infection
|
M. Spina
|
|
1999
|
10 |
11 |
p. 1271-1286
16 p.
|
artikel
|
| 48 |
Next stop - PubMed Central
|
|
|
|
10 |
11 |
p. 1262-1263
|
artikel
|
| 49 |
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU ± FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program
|
Brienza, S.
|
|
|
10 |
11 |
p. 1311-1316
|
artikel
|
| 50 |
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU ± FA) inthe treatment of 5-FU-pretreated patients with advanced colorectal carcinoma(ACRC): Results from the European compassionate-use program
|
S. Brienza
|
|
1999
|
10 |
11 |
p. 1311-1316
6 p.
|
artikel
|
| 51 |
Pancreatitis during therapy of acute myeloid leukemia: Cytarabine related?*
|
McGrail, L.H.
|
|
|
10 |
11 |
p. 1373-1376
|
artikel
|
| 52 |
Pancreatitis during therapy of acute myeloid leukemia: Cytarabinerelated?
|
L. H. McGrail
|
|
1999
|
10 |
11 |
p. 1373-1376
4 p.
|
artikel
|
| 53 |
Perhaps not everyone knows that…
|
|
|
|
10 |
11 |
p. 1264-1267
|
artikel
|
| 54 |
Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancer
|
Schiphorst, P.P.
|
|
|
10 |
11 |
p. 1381-1383
|
artikel
|
| 55 |
Pharmacokinetics of interleukin-2 in two anephric patients withmetastatic renal cell cancer
|
P. P. Schiphorst
|
|
1999
|
10 |
11 |
p. 1381-1383
3 p.
|
artikel
|
| 56 |
Prognostic factors for subdiaphragmatic involvement in clinical stage I–II supradiaphragmatic Hodgkin’s disease: A retrospective analysis of the GHSG
|
Rueffer, U.
|
|
|
10 |
11 |
p. 1343-1348
|
artikel
|
| 57 |
Prognostic factors for subdiaphragmatic involvement in clinical stage III supradiaphragmatic Hodgkins disease: A retrospective analysis of the GHSG
|
U. Rueffer
|
|
1999
|
10 |
11 |
p. 1343-1348
6 p.
|
artikel
|
| 58 |
Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stress
|
Siitonen, T.
|
|
|
10 |
11 |
p. 1361-1367
|
artikel
|
| 59 |
Protection of acute myeloblastic leukemia cells against apoptotic celldeath by high glutathione and gamma-glutamylcysteine synthetase levels duringetoposide-induced oxidative stress
|
T. Siitonen
|
|
1999
|
10 |
11 |
p. 1361-1367
7 p.
|
artikel
|
| 60 |
R. Kurzrock, M. Talpaz (eds)., Molecular biology in cancer medicine
|
F. Bertoni
|
|
1999
|
10 |
11 |
p. 1268-1268
1 p.
|
artikel
|
| 61 |
Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: A re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses
|
Thirion, P.
|
|
|
10 |
11 |
p. 1317-1320
|
artikel
|
| 62 |
Survival impact of chemotherapy in patients with colorectal metastasesconfined to the liver: A re-analysis of 1458 non-operable patients randomisedin 22 trials and 4 meta-analyses
|
P. Thirion
|
|
1999
|
10 |
11 |
p. 1317-1320
4 p.
|
artikel
|
| 63 |
Table of Contents
|
|
|
|
10 |
11 |
p. iii-iv
|
artikel
|
| 64 |
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: Results from the 1997 American Society of Clinical Oncology survey
|
Bennett, C.L.
|
|
|
10 |
11 |
p. 1355-1359
|
artikel
|
| 65 |
The association between physician reimbursement in the US and use ofhematopoietic colony stimulating factors as adjunct therapy for older patientswith acute myeloid leukemia: Results from the 1997 American Society ofClinical Oncology survey
|
C. L. Bennett
|
|
1999
|
10 |
11 |
p. 1355-1359
5 p.
|
artikel
|
| 66 |
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer
|
Baekelandt, M.
|
|
|
10 |
11 |
p. 1335-1341
|
artikel
|
| 67 |
The significance of metastasis-related factors cathepsin-D and nm23 inadvanced ovarian cancer
|
M. Baekelandt
|
|
1999
|
10 |
11 |
p. 1335-1341
7 p.
|
artikel
|
| 68 |
Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study
|
Johnson, P.W.M.
|
|
|
10 |
11 |
p. 1349-1354
|
artikel
|
| 69 |
Variability of polymerase chain reaction detection of thebcl-2IgH translocation in an international multicentrestudy
|
P. W. M. Johnson
|
|
1999
|
10 |
11 |
p. 1349-1354
6 p.
|
artikel
|
Tijdschrift beschrijving